Franchise Global Health Inc. (TSXV:FGH) signed an initial term sheet to acquire 100% of the shares of Phatebo for €15.1 million on August 7, 2019. On December 29, 2020, Franchise entered into a share purchase agreement to acquire 100% of the issued and outstanding common shares of Phatebo. The purchase price was set at €8 million and € 4.082 million, which was to be paid over two tranches. First tranche due and payable on December 29, 2020 and consisting of €3.5 million as a cash payment and Franchise shares (3,846,154 of FCC Shares each at an agreed price of €1.06132 per share). This payment was made in January 2021. Second tranche due and payable on closing and consists of €4.5 million. This payment was made on December 31, 2021.

Franchise Global Health Inc. (TSXV:FGH) completed the acquisition of 100% stake in Phatebo for €15.1 million on December 31, 2021.